Denali Therapeutics Inc. (DNLI) Operating margin 2018–2023
Denali Therapeutics Inc. (DNLI) operating margin by fiscal year — reported operating income divided by reported revenue.
-59.5%FY2023 · since FY2018: -35.9% → -59.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -59.5% | +264.8 pp |
| FY2022 | -324.3% | +283.5 pp |
| FY2021 | -607.8% | -626.5 pp |
| FY2020 | 18.7% | +828.7 pp |
| FY2019 | -810.0% | -774.1 pp |
| FY2018 | -35.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice